Brief: Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China
09/11/2023 13:15
Nov 9 (Reuters) - Establishment Labs Holdings Inc
ESTA.O :
* ESTABLISHMENT LABS HOLDINGS - RECEIVED NATIONAL MEDICAL
PRODUCTS ADMINISTRATION APPROVAL IN CHINA FOR MOTIVA IMPLANTS
Source text for Eikon: ID:nBw5qFy83a
Further company coverage: ESTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Establishment Labs Holdings
See all newsU.S. STOCKS ON THE MOVE-Nike, Synopsys, Intel
U.S. STOCKS ON THE MOVE- Cenovus Energy, TeraWulf, Alector
Establishment Labs gains on US FDA approval for more Motiva implant sizes
Brief: Establishment Labs Receives FDA Approval For Additional Sizes Of Motiva Implants
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp